Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000711324 | SCV000841665 | benign | not provided | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026802 | SCV000847201 | likely benign | not specified | 2016-07-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000711324 | SCV001022902 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000711324 | SCV005225813 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003907967 | SCV004731859 | benign | CRH-related disorder | 2019-10-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |